Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Agriculture
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- University / Academia / Research
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Mining
- Automobile & Ground Transport
- Domestic
- Retail
- Logistics
- Soil and Groundwater
- Manufacturing, Other
- Food and Beverage
- Energy
Disease Detection Suppliers Serving Guinea
85 companies found
based inLondon, UNITED KINGDOM
Applied Nanodetectors was formed in 2004 and is a leading developer and supplier of nanosensor based solutions for environmental, healthcare and medical worldwide markets. Improving peoples quality of life with our products. Dedicated to delivering ...
Exhale-Dx™ Is A Non-Invasive Point Of Care Device, That Implements Breath Analysis To Forecast Your Future Diagnosis. This Provides The Patient With Personalised ...
based inVillejuif, FRANCE
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to ...
based inMonmouth Junction, NEW JERSEY (USA)
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...
microRNAs are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production, and whose levels often change in disease. Certain microRNAs are enriched, i.e. present at higher ...
based inBillerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
based inSauerlach, GERMANY
LOEWE was established in 1988 as an independent, privately owned company. As one of the commercial pioneers in the plant disease detection sector, the company started with the distribution of antisera for ELISA detection of plant viruses, produced ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) Panel is designed to overcome the limitations of analyzing clinical diseases with conventional whole-exome ...
based inAnn Arbor, MICHIGAN (USA)
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by ...
based inMarlborough, MASSACHUSETTS (USA)
When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life™s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the ...
Daytona produces a 200° single-capture optomap retinal image of unrivaled clarity in less than ½ second. This fast, easy, patient-friendly, ultra-widefield imaging technology was designed for healthy eye screening and has been shown to ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
A majority of individuals with CD do not recover well under a GFD. Furthermore, there is still no effective means for monitoring the intestinal health of a recovering celiac other than an invasive biopsy and even that method is prone to interpretive ...
based inCharlestown, MASSACHUSETTS (USA)
Seven Bridges is the leading biomedical data company, specializing in software and data analytics to drive public and private healthcare research. We deliver end-to-end bioinformatic solutions including access to datasets, analytic workflows and ...
The representation of the human reference genome as a linear haploid DNA sequence poses limitations when trying to incorporate the known genetic diversity of human populations. This has led to the development of graph-based references, able to ...
based inMainz, GERMANY
Fuelled by Innovation: With a pioneering spirit and high technical expertise, ORGENTEC has become firmly established in medical diagnostics. Our employees’ talent and skills establish the basis for our success. At our headquarters in Mainz, Germany, ...
AMA-M2 is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against mitochondrial M2 subtype antigen in human serum or plasma. Anti-mitochondrial antibodies (AMA) are a heterogeneous group of ...
based inValencia, SPAIN
Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range ...
based inLuhe District, CHINA
Getein Biotech Inc. (stock code: 603387), established in 2002 and headquartered in Nanjing, is a fully integrated in vitro diagnostic (IVD) company that researches, manufactures, markets and distributes analytical medical devices and a broad range ...
Getein Biotech Inc. has a high-quality research and development team of “key medical talents”, with strong technical and R&D advantages. At present, there are nearly 300 professionals engaged in high-tech research and development, ...
based inKatrineholm, SWEDEN
With a heritage of over a hundred years, Sveaverken Svea Agri AB has a long tradition of driving innovations in the farming and husbandry sectors in the Nordic region. Today, Sveaverken is devoted to transforming the traditional agriculture industry ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
based inChicago, ILLINOIS (USA)
Igenbio, Inc. develops genome analysis products and services for the life science industry. Our scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. Annual imaging (low-dose CT scans) is ...
based inBensheim, GERMANY
We are a globally orientated German company with innovative products in the sector of point-of-care diagnostics and telemedical solutions that are used in clinics, practices and in everyone’s everyday life. Preventis GmbH was founded 2003 in ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with ...
